cas 924-99-2|| where to buy Ethyl 3-(dimethylamino)acrylate

Nom du produit:Ethyl 3-(dimethylamino)acrylate

IUPAC Name:ethyl 3-(dimethylamino)prop-2-enoate

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM194823-1000g	in stock	ƛƥ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 924-99-2 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:924-99-2; Formule moléculaire:C7H13NO2; Point de fusion:-; Code SMILES:CCOC(=O)C=CN(C)C; Densité:

: Numéro de catalogue:CM194823; Poids moléculaire:143.19; Point d'ébullition:185.9°C at 760 mmHg; N° Mdl:MFCD00144269; Stockage:Store at 2-8°C.

: Amino Acids and Peptides; Amino acids are organic compounds containing a basic amino group and an acidic carboxyl group. Because amino acids contain both amino and carboxyl groups, they can be polymerized in an end-to-end manner, removing a molecule of water to form a covalent amide bond or peptide bond. Many amino acids are linked together end to end to form a polypeptide. Amino acids and peptides are important components in the fields of medicine and life sciences.; amino acids wholesale; if you are finding amino acids wholesaler in china, we will be your best choose! We have our own factory, so we can give you a cheap price!

: BNC-210; Bionomics Ltd.’s drug candidate, BNC-210 would be advanced into Phase 3 studies in Social Anxiety Disorder (SAD) after the successful End-of-Phase 2 Meeting with the U.S. FDA in September. BNC-210 has a unique action potential that depends on acetylcholine neurotransmission and allosteric modulation of α7 nAChR. It is designed to treat patients with serious central nervous system (CNS) disorders with limited side effects. BNC-210 received Fast-Track designation from the FDA for the acute treatment of SAD.